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72 The Journal of Thoracic and Cardiobjective: Neonatal complex cardiac surgery carries a significant risk for adverse
eurodevelopmental outcome. We hypothesized this risk to be higher in patients
ith deletion 22q11.2.
ethods: From 1996 to 2004, neonates who had complex cardiac surgery at age 6
eeks or less had multisite, multidisciplinary health and neurodevelopmental out-
omes (Bayley Scales of Infant Development II; mental and psychomotor develop-
ental indices [MDI, PDI] as mean [SD] and delay [70]) assessed at 18 to 24
onths of age. All 16 patients with deletion 22q11.2 (group 1) were compared with
6 patients without deletion 22q11.2 (group 2) having undergone neonatal complex
ardiac surgery at the same center and matched for cardiac lesion, socioeconomic
tatus, and year of operation. Outcomes were compared by univariate and multi-
ariate analyses.
esults: Heart lesions in each group consisted of 6 (37.5%) cases of interrupted
ortic arch, 6 (37.5%) cases of truncus arteriosus, and 4 (25%) cases of tetralogy of
allot. Outcomes were available for all survivors. Mortality was 3 (19%) and 1 (6%)
n groups 1 and 2, respectively (P  .6). MDI and PDI scores were 66.1 (10.6) and
5.0 (9.4) for group 1 and 86.3 (14.6) and 82.3 (14.3) for group 2 (P  .001). Only
eletion 22q11.2 was significant in stepwise multiple regression to predict MDI and
DI scores. Mental delay occurred in 8 (61.5%) of 13 in group 1 and 2 (13.8%) of
5 in group 2 (P .016). Psychomotor delay occurred in 11 (84.6%) of 13 in group
and 1 (6.7%) of 15 in group 2 (P  .001).
onclusion: Neonates affected by deletion 22q11.2 and having neonatal complex
ardiac surgery have significantly worse neurodevelopmental outcome than do those
ithout deletion 22q11.2.
everal studies have demonstrated that some neonates and infants undergoing
complex cardiac surgery (CCS) for congenital heart disease (CHD) have an
abnormal neurodevelopmental outcome when evaluated at as early as 1 or 2
ears of life.1-5 Patients with deletion 22q11.2 (del22q11.2) may have worse motor
nd neurologic development than other children after CCS.6-8 A large single-
nstitution study investigating the neurodevelopment of 5-year-old children after
arlier repair or palliation of CHD showed that lower socioeconomic status and
el22q11.2 were associated with significantly lower full-scale intelligence quotient
IQ) scores.6 Maharasingam and associates7 compared the neurodevelopmental
tatus of 10 children (mean age 3.6 years) with del22q11.2 with 20 matched
ontrols, both after cardiac surgery in the first year of life. Using the Ruth Griffiths
est, they found a lower developmental quotient in the del22q11.2 group.7 Swillen
nd colleagues8 evaluated 11 children (mean age 41 months) with del22q11.2 and
vascular Surgery ● September 2007
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Donotruncal defects repaired in the first year of life, showing
ignificant fine and gross motor delay when compared with
hildren with the same types of conotruncal defects.
There are no reports of which we are aware evaluating
he neurodevelopmental outcome after neonatal CCS in
atients with and without del22q11.2. Therefore, we sought
o compare the general and neurodevelopmental outcomes
t 18 to 24 months between subjects with and without
el22q11.2 who underwent neonatal ( 6 weeks of age)
CS for CHD at the same institution.
atients and Methods
his is a case–comparison within cohort study using data from an
nterprovincial inception cohort outcomes study conducted in three
rovinces in Western Canada. As previously described,4,5 from
eptember 1996 through August 31, 2004, infants 6 weeks of age
r younger were identified at the time of CCS. Surgery was
erformed at the Stollery Children’s Hospital, Edmonton, Alberta,
anada.
Preoperative, intraoperative, and postoperative variables that
ere previously agreed on were collected prospectively.4,5 Long-
erm follow-up was discussed with parents or guardians once
urvival was probable, and with their consent, contact was made
ith their respective follow-up clinics at the tertiary site of origin.
ubjects
ll consecutive patients with del22q11.2 identified over the 8-year
eriod were registered (group 1). A comparison group of patients
atched for type of CHD, socioeconomic status, and year of
peration were identified (group 2). The inclusion criteria were as
ollows: (1) CCS (requiring use of cardiopulmonary bypass) at the
tollery Children’s Hospital, (2) CCS performed from September
996 to August 31, 2004, and (3) CCS at 6 weeks of age or less.
he exclusion criteria were as follows: (1) chromosomal anoma-
ies or syndromes other than del22q11.2 and (2) CHD surgery not
equiring cardiopulmonary bypass. All patients in group 1 had the
el22q11.2 confirmed by either DNA analysis or fluorescence in
itu hybridization using standard probes.9,10 All patients in the
omparison group had a normal karyotype and DNA analysis. All
Abbreviations and Acronyms
CCS  complex cardiac surgery
CHD  congenital heart disease
del22q11.2 deletion 22q11.2
IAA  interrupted aortic arch
IQ  intelligence quotient
MDI mental developmental index
PA  pulmonary atresia
PDI  psychomotor developmental index
SD  standard deviation
TA  truncus arteriosus
TOF  tetralogy of Fallot
VSD  ventricular septal defecturvivors received multidisciplinary neurodevelopmental assess- p
The Journal of Thoracicents through existing neonatal follow-up clinics in Edmonton
nd Calgary, Alberta; Regina and Saskatoon, Saskatchewan; and
innipeg, Manitoba. Ethics board approvals were obtained from
ach site before the onset of the study. All parents or guardians
igned individual consent forms.
arly Childhood Assessments
utcomes assessment was completed at 18 to 24 months of age. At
ssessment, a research nurse recorded history of hospitalizations,
llnesses, medication use, and need for supplemental oxygen.
hysical measurements were obtained as have been described.4,5
he family socioeconomic status was determined by the Blishen
ndex, a formula considering the relative income, needed educa-
ion, and prestige factor of employment with a population mean
nd standard deviation (SD) of 43 (13).11 Maternal education was
ndicated by years of schooling. Pediatricians experienced in neu-
odevelopmental follow-up examined each child for evidence of
erebral palsy12 or visual impairment defined as corrected visual
cuity in the better eye of less than 20/60.4,5 Hearing was evalu-
ted by experienced certified pediatric audiologists in soundproof
nvironments as has been described.4,5 Hearing impairment was
efined as binaural sensorineural hearing loss of more than 40 dB
t any frequency from 250 to 4000 Hz. Certified pediatric psy-
hologists and psychometrists administered the Bayley Scales of
nfant Development II,13 a widely accepted standardized outcome
easure used in neonatal follow-up clinics yielding separate men-
al (MDI) and psychomotor developmental index (PDI) standard-
zed scores with a mean of 100 and an SD of 15. Developmental
ndices of less than 70 (2 SD below the mean) indicated mental or
otor delay. Within a normative sample, 2.27% of children have
cores of less than 70. Behavioral indices were also recorded with
ercentiles at or below 10 considered as nonoptimal scores.
tatistics
emographic variables included gestational age, birth weight,
ender, prenatal diagnosis, race, year of operation, socioeconomic
tatus, mother’s year of schooling, guardianship, home location,
nd out-of-region referral. Preoperative variables included cardiac
iagnoses, cardiopulmonary resuscitation, seizure, highest plasma
actate, and lowest pH and arterial oxygen tension. Intraoperative
ariables included cardiopulmonary bypass time, aortic cross-
lamp time, deep hypothermic circulatory arrest use and time, and
eed for reinstitution of bypass in the operating room. Postopera-
ive variables included highest plasma lactate on day 1 and days 2
o 5, seizure, extracorporeal life support, cardiopulmonary resus-
itation, duration of postoperative ventilation, and overall duration
f ventilation and hospitalization. The primary outcomes of inter-
st were the neurodevelopmental indices obtained from the Bayley
cales of Infant Development II (MDI and PDI). The secondary
utcomes included mortality and morbidity. Morbidity was de-
ned by the health and growth variables, which included height,
eight, head circumference, number of cardiac and noncardiac
ospitalizations, number of illnesses requiring a physician’s care,
umber of specialist physicians involved in the care, specialized
are required, use of oxygen, special diet, or gastrostomy tube,
ong-term cardiac or pulmonary medication, and pacemaker use.
For comparison of the two matched groups, before deaths, the
aired-samples t test and Wilcoxon 2–related samples test for
and Cardiovascular Surgery ● Volume 134, Number 3 773
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Dontinuous data and the McNemar test for dichotomous variables
ere used. Descriptive variables for surviving subjects were ana-
yzed by the univariate t test, 2 test, and Fisher exact test (2-sided)
nalyses. Bonferonni correction was applied. Sequential stepwise
ultiple regression for variables from each of the stages (preop-
rative, operative, postoperative) were used to explore the overall
reatest proportion of developmental outcome explained by a
ombination of predictors to a significance level of .05. SPSS
SPSS, Inc, Chicago, Ill) version 12.0 for Windows was used for
nalyses.
esults
escription of Cohort
here were 16 patients in each group. Complete follow-up
ata were available for all patients. The groups were well
atched. Each group comprised 6 (37.5%) patients with
nterrupted aortic arch (IAA), 6 (37.5%) patients with trun-
us arteriosus (TA), and 4 (25%) patients with tetralogy of
allot (TOF). Ten patients had IAA type B (IAA-B) and 2
both in group 2) had type A (IAA-A). The socioeconomic
tatus was 43.9 (15.2) and 39.4 (11.2) in group 1 and group
, respectively (P  not significant). The year of surgery
as 2000.6 (2.8) and 2001.1 (2.2) in group 1 and group 2,
espectively (P  not significant). In addition, demo-
raphic, preoperative, operative, and postoperative vari-
bles showed no statistically significant differences between
he two groups when comparing the entire cohort. Only 1
atient (group 2) required extracorporeal life support post-
peratively. Only 1 patient in each group required preoper-
tive ventilation. Only 2 patients had preoperative convul-
ions, both in group 1, and they both died.
econdary Outcomes
hree patients (1 with IAA-B and 2 with TOF) in group 1
nd 1 (TA) in group 2 died, for mortality rates of 19% (3/16)
nd 6% (1/16), respectively (P  .60). Of the 4 deaths, the
tiology was cardiac in 2, respiratory in 1, and unknown in 1.
Demographic, preoperative, operative, and postoperative
ariables were compared between survivors in group 1 (n
3) and group 2 (n  15) and showed no statistically
ignificant differences (Table 1). Health and growth out-
omes among survivors are shown in Table 2. Use of
ong-term pulmonary medications was significantly differ-
nt (P  .005), with 6 (46%) of 13 patients in group 1 and
(0%) of 15 in group 2 requiring these medications at
ollow-up. There were no subjects in either group with
erebral palsy or visual or sensorineural hearing disabilities.
rimary Outcomes
ollow-up was achieved in all survivors and performed at a
ean age of 22 (4) months. The average MDI (66.1 [10.6]
s 86.3 [14.6], t test  4.129, P  .001) and PDI (55.0
9.4] vs 82.3 [14.3], t test5.872, P .001) scores were l
74 The Journal of Thoracic and Cardiovascular Surgery ● Septeignificantly lower in group 1 than in group 2 (Figure 1).
ental delay (MDI  70) occurred in 8 (61.5%) of 13 in
roup 1 compared with 2 (13.8%) of 15 in group 2 (P 
016) (Table 3). Psychomotor delay (PDI  70) occurred in
1 (84.6%) of 13 in group 1 and 1 (6.7%) of 15 in group 2
P  .001) (Table 3). Of the 2 patients in group 2 with
ental delay, 1 had dehydration and shock resulting from a
otavirus gastrointestinal illness in infancy, and the other
as the only patient requiring postoperative extracorporeal
ife support. Mental and/or psychomotor delay occurred in
2 (92%) of 13 in group 1 and 2 (13%) of 15 in group 2
P  .001) (Table 3). Almost all (12/13) children with
el22q11.2 had poor motor quality for age (Table 3).
We compared demographic, preoperative, intraoperative,
nd postoperative variables between patients with and with-
ut mental and/or psychomotor delay and found no statis-
ically significant differences except for the del22q11.2 di-
gnosis: 1 (7.1%) of 14 patients without delay and 12
85.7%) of 14 patients with delay (Fisher exact test, P 
001). All demographic, preoperative, intraoperative, and
ostoperative variables were examined for their correlation
ith MDI and PDI scores. The variables with correlation at
 0.1 (Table 4) were entered into stepwise multiple
egression analyses. The del22q11.2 diagnosis accounted
or 27% of the variability in MDI score (adjusted r2 .274,
 .003), and 61% of the variability in PDI scores (ad-
usted r2  .613, P  .001). No other variable was signif-
cant in the stepwise multiple regression analyses.
iscussion
o our knowledge, this is the first report describing the 18-
o 24-month neurodevelopmental outcomes of patients with
el22q11.2 identified as neonates requiring CCS. All
el22q11.2 patients had neonatal CCS and were compared
ith patients without del22q11.2 having neonatal CCS,
eing matched for cardiac lesion, year of operation, and
ocioeconomic status. We found that these neonates with
el22q11.2 have a high risk for compromised neurodevel-
pmental outcome on follow-up, characterized by signifi-
antly lower MDI and PDI scores and significantly higher
ates of motor and mental delay than in the matched com-
arison group (Figure 1, Table 3). We compared demo-
raphic, preoperative, intraoperative, and postoperative
ariables between the del22q11.2 group and comparison
roup and found no significant differences (Table 1). These
ariables were also compared between patients with and
ithout delay, and no differences were detected except for
he diagnosis of del22q11.2. Moreover, stepwise multiple
egression analyses found that del22q11.2 accounted for a
ignificant portion of the variability in MDI and PDI scores.
hese results corroborate and complement the limited pub-ished data showing lower developmental quotient and
mber 2007
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Dcores, significant motor delay, and lower IQ scores for
el22q11.2 patients compared with other children with sur-
ically repaired CHD.6-8
Chromosome 22q11.2 deletion (del22q11.2) is the most
ommon known genetic microdeletion syndrome. Its prev-
lence is estimated at 1 per 3000 to 6000 in the general
opulation.14,15 The presentation of del22q11.2 lies along a
ide phenotypic spectrum including more than 180 fea-
ures, with the most common phenotypes being CHD,
ypocalcemia, immunodeficiency, facial dysmorphisms,
ABLE 1. Descriptive variables of 13 survivors with del22q
ubjects (group 2)
Total (n  28) Gro
emographic/preoperative
Socioeconomic status 41.3 (13.9)
Mother’s years of schooling 13.0 (1.8)
Guardianship: both parents 25 (92.8%)
Race: white 24 (85.7%)
Location of home: large urban 17 (60.7%)
Referral from out of region 15 (53.6%)
Sex: male 18 (64.3%)
Gestational age: wk 38.9 (2.2)
Birth weight: g 3202 (725) 3
Major cardiac diagnosis
Interrupted aortic arch
Type B 9 (32.1%)
Type A 2 (7.1%)
Truncus arteriosus 11 (39.4%)
Tetralogy of Fallot 6 (21.4%)
Cardiorespiratory arrest 1 (3.6%)
Convulsions 0
Highest plasma lactate (mmol/L) 3.1 (5.1)
Lowest arterial pH 7.33 (.09)
Lowest PaO2 (mm Hg) 55.3 (21.9)
No. of children ventilated 2 (7.1%)
ntraoperative
CPB (min) 116.1 (40.1) 1
Aortic crossclamp time (min) 56.4 (26.4)
DHCA used 16 (57.1%)
DHCA time (n  16) (min) 44.6 (17.1)
Need for re-CPB in OR 3 (10.7%)
ostoperative
Highest plasma lactate, day 1 5.9 (3.5)
Highest plasma lactate, day 2 to 5 2.7 (1.4)
Seizures 3 (10.7%)
ECLS 1 (3.6%)
Cardiopulmonary resuscitation 1 (3.6%)
verall
Duration of ventilation 17.3 (30.6)
Duration of hospitalization 36.1 (46.4)
el22q11.2, Deletion 22q11.2; CCS, complex cardiac surgery; CPB, cardiopul
CLS, extracorporeal life support; Values are mean (SD) or n (%). *2 Analatal abnormalities, velopharyngeal dysfunction, and neu- m
The Journal of Thoracicologic, behavioral, and developmental disorders.16 CHD is
he most common structural anomaly in patients with
el22q11.2, affecting up to 70% to 80%.14,15,17 A popula-
ion-based study14 and studies looking at the prenatal18,19
nd postnatal20,21 prevalence of the most common conotrun-
al congenital heart defects have revealed consistent find-
ngs.14,18-21 Del22q11.2 is found in up to 50% of patients
ith IAA, 20% to 30% with TA, 12% to 20% with TOF,
nd 20% to 30% with pulmonary atresia and ventricular
eptal defect (PA-VSD).14,18-21 That del22q11.2 is this com-
and CCS at <6 weeks of age (group 1) and 15 comparison
Subjects 2, t test, Fisher
exact test*(n  13) Group 2 (n  15) P value
15.9) 38.1 (11.5) 1.3248 .189
1.8) 12.7 (1.8) 1.163 .255
100%) 12 (80%) — .562
84.6%) 13 (86.7%) — .999
53.8%) 10 (66.7%) — .692
53.8%) 8 (53.3%) — .999
61.5%) 10 (66.7%) — .999
2.9) 39.2 (1.5) .749 .464
844) 3252 (629) .382 .705
2.037 .361
38.5%) 4 (26.7%)
0%) 2 (13.3%)
46.2%) 5 (33.3%) — .700
15.4%) 4 (26.7%) — .655
0%) 1 (6.7%) — .999
0 0
.7) 4.1 (6.9) 1.107 .286
.07) 7.33 (.11) .262 .795
20.7) 59.9 (22.5) 1.192 .244
7.7%) 1 (6.7%) — .999
34.8) 121.2 (44.8) .719 .498
22.3) 62.5 (28.9) 1.340 .192
61.5%) 8 (53.3%) — .942
22.8) 46.1 (10.1) .355 .730
7.7%) 2 (13.3%) — .999
3.0) 6.7 (3.9) 1.361 .186
1.2) 2.6 (1.6) .499 .622
15.3%) 1 (6.7%) — .899
0%) 1 (6.7%) — .999
0%) 1 (6.7%) — .999
20.5) 17.9 (37.9) .286 .777
40.5) 33.7 (52.3) .106 .916
ry bypass; DHCA, deep hypothermic circulatory arrest; OR, operating room;
, Student t test, Fisher exact test.11.2
up 1
45.1 (
13.5 (
13 (
11 (
7 (
7 (
8 (
38.5 (
145 (
5 (
0 (
6 (
2 (
0 (
2.1 (
7.32 (
50.1 (
1 (
10.2 (
49.3 (
8 (
43.0 (
1 (
5.0 (
2.8 (
2 (
0 (
0 (
16.6 (
38.9 (
monaon adds to the significance of our findings.
and Cardiovascular Surgery ● Volume 134, Number 3 775
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DAs in our study, neurodevelopmental abnormalities in
ohorts of children with del22q11.2 have been found by
ther authors. Motor disability and delay in acquisition of
otor skills in del22q11.2 patients of different age groups
ave been documented by some investigators.2,8,22,23 The
tiology of the psychomotor delay in this patient population
s unclear. Hypotonia may be a contributing factor to the
evelopment of motor delay. Mental delay has also been
hown among del22q11.2 patients of different pediatric age
roups. Gerdes and colleagues,22,23 in 2 studies of patients
eferred to their genetic center, showed that preschool chil-
ren with del22q11.2 have mild–to–moderate developmen-
al delay, mild hypotonia, and language and speech delay.
heir patients assessed at ages 12 to 42 months with the
ayley Scales of Infant Development II had mean MDI and
DI scores of 69.8 (15) and 60.1 (12), respectively.22 They
eported a 46.4% incidence of mental delay (MDI 70) and
9% for motor delay (PDI  70).22 In a subsequent article
ith a larger patient number accumulated, the incidence of
ental delay (MDI  70) in toddlers was 58%.23 When
omparing nonmatched patients with (n  29) and without
HD (n  11), they found no difference in MDI mean
cores (66.6 [18] vs 71 [14]).22 Niklasson and colleagues24
xamined 30 children with del22q11.2 aged 7 to 13 years
ABLE 2. Health and growth outcomes of 13 children aged
atched survivors (group 2)
Tot
o. of hospitalizations for illness not related to heart 3.
o. of hospitalizations related to heart .2
o. of other illnesses requiring doctor’s care (not check-up) 4.
o. of specialists currently seen excluding primary care
physicians
2.
pecialized care
Regular pulmonary specialist for asthma, aspiration, reflux
Myringotomies
Cleft palate repair
Tracheostomy
Left vocal cord paralysis
urrent use of supplemental oxygen
urrent use of special or supplemental diet 1
urrent use of gastrostomy
edically fragile†
hronic pulmonary medication
hronic cardiac medication
acemaker
ength  third percentile
eight  third percentile
icrocephaly
alues are mean (SD) or n (%). *2 Analysis, Student t test, Fisher exact te
onferonni correction, a P value of  .005 would be considered significand showed a high incidence of attention deficit hyperac- c
76 The Journal of Thoracic and Cardiovascular Surgery ● Septeivity disorder (mainly the inattentive type) and nonverbal
earning disability. Del22q11.2 patients are also at higher
isk for the development of schizophrenia.15 The association
f del22q11.2 cognitive deficits with brain structural abnor-
alities has been suggested.25,26
Del22q11.2 has been suggested to be a risk factor for
ncreased mortality after repair of conotruncal CHD. In a
-year prospective multicenter study, Anaclerio and col-
eagues27 showed that among patients with conotruncal
efects, del22q11.2 was a risk factor for higher surgical
ortality in children with PA-VSD and IAA, but not in
hose with TOF or TA. Mahle and colleagues21 demon-
trated that the 5-year survival after surgical repair of PA-
SD was lower in patients affected by del22q11.2 (36% vs
0% in those without del22q11.2, P  .001). In contrast,
nother study did not detect any difference in morbidity or
ortality between patients with and without del22q11.2
fter cardiac surgery.28 In our study, owing to the small
umber of patients, we did not have enough power to test
or difference in mortality and hence could not confirm or
efute the previous studies.
Some literature suggests that genetic counseling in
el22q11.2 is a difficult task, for the syndrome carries
npredictable variability in its phenotypic presentation, in-
to 24 months with del22q11.2 (group 1) and 15 comparison
Subjects 2, t test, Fisher
exact test* 28) Group 1 (n  13) Group 2 (n  15) P value
) 4.2 (6.6) 3.1 (7.8) 0.395 .696
0.0 (0.0) 0.47 (0.7) 2.432 .029
) 6 (7.7) 3.8 (4.9) 0.908 .372
) 2.9 (1.6) 1.9 (1.2) 1.886 .070
7 2 Not computed
4 0
2 1
1 0
3 4
%) 2 (15.4%) 0 (0%) — .206
.9)% 6 (53.8%) 6 (40%) — .486
.4%) 3 (23.1%) 3 (20%) — .928
.7%) 3 (23.1%) 0 (0%) — .087
.4%) 6 (46.2%) 0 (0%) — .005
.7%) 1 (7.7%) 2 (13.3%) — .999
.7%) 0 (0%) 3 (20%) — .226
.3%) 4 (30.8%) 0 (0%) — .035
%) 1 (7.7%) 1 (6.7%) — .999
%) 2 (15.4%) 0 (0%) — .510
edically fragile—long-term hospitalization or in-home nursing care. After18
al (n
6 (7.1
5 (.6)
8 (6.4
4 (1.4
9
4
3
1
7
2 (7.1
2 (42
6 (21
3 (10
6 (21
3 (10
3 (10
4 (14
2 (7.1
2 (7.1
st. †Mluding neurodevelopmental profile. Our data may allow for
mber 2007
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CH
Dore guided and informed antenatal and postnatal counsel-
ng to families with neonates affected by the chromosome
2q11.2 deletion syndrome who require neonatal CCS. In
ddition, considering the long-term medical and neurobe-
avioral outcomes, some argue that parents with a fetal
iagnosis of CHD possibly associated with 22q11.2 dele-
ion, such as conotruncal anomalies, should be offered the
ption of prenatal screening for del22q11.2.29 Furthermore,
arly intervention may be instrumental in helping this
pecific patient population to optimize neurologic and
hysical developmental potential and hence level of func-
ioning in society. This need for early intervention has
reviously been emphasized.22,23 In our cohort, 9 (69%)
f the 13 del22q11.2 patients received developmental
ntervention compared with 3 (20%) of 15 in the com-
arison group (P  .027).
The contribution of del22q11.2 to the delay of these
hildren after CCS requires further evaluation. By ap-
roaching this question from a perspective of a case–
omparison study, we have shown scores below normative
alues for both study groups. For young children after CCS
or IAA, TA, and TOF in the neonatal period, but without
hromosomal abnormalities, the proportion with mental de-
ay is 6 times larger and the proportion with motor delay is
times larger than that seen in a normative sample. This
rticle does not explore all of the operative and periopera-
ive reasons for this delay, but, as we have reported previ-
usly,4 it does show that these children without chromo-
omal abnormalities have some developmental concerns.
owever, this article also shows that the children with
el22q11.2 after neonatal CCS and otherwise matched to
he comparison children have significantly lower scores
han the matched group, with the proportion with mental
elay 27 times larger and the proportion with motor delay
7 times larger than that in a normative sample.
Using sequential stepwise multiple regression, we at-
empted to address the question of the proportion of out-
ome contributed to by CCS for those with del22q11.2. We
ound that 27% of the variability of the mental scores and
1% of the variability of the motor scores in the combined
ohort are explained by the chromosomal abnormality. This
eaves 73% of mental and 39% of motor scores’ variability
nexplained by this study. In addition to the CCS variables,
auses that could relate to delay among the del22q11.2
roup include ongoing childhood illness, more common in
his group. This study is not designed to evaluate other types
f surgery for children with del22q11.2, and it gives no
ndication that a change in surgical approach should be
onsidered. The study supports the concept that children
ith del22q11.2 do less well than matched comparison
hildren under the same clinical conditions and that motor
cores and motor quality are at greatest risk. It should beigure 1. A, Mental developmental index in survivors with
el22q11.2 (n  13, group 1) and a comparison group (n  15,
roup 2). B, Psychomotor developmental index in survivors with
el22q11.2 (n  13, group 1) and comparison group (n  15, group
). The thick line inside the box represents the median, the box is
ormed of the first to the third quartiles (25% and 75%), with the
hiskers extending to the minimum and maximum value that is
ot considered an outlier. The circles and stars represent outliers
more than 1.5 times the interquartile range from the first and third
uartiles).oted that the mean mental score of the del22q11.2 children
and Cardiovascular Surgery ● Volume 134, Number 3 777
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CH
Dn this study is 66.1, almost identical to that of the children
eported on by Gerdes and associates,22 where the mean
core was 66.6 for those with CHD.
A limitation of this study is the small number of patients
espite the 8-year surgical period and the high yearly sur-
ical volumes. It is not possible to assess whether this
umber is representative of the expected incidence of
el22q11.2 in the general population because we studied a
elective cohort of neonates with CHD. In addition, the rate
f termination of fetuses with an antenatal diagnosis of
el22q11.2 and CHD is unknown. The small number of
tudy patients did not allow subgroup analysis of the dif-
erent cardiac lesions. Finally, the restricted selection of
atients undergoing CCS at 6 weeks of age or less accounts
or the different distribution of the cardiac phenotypes in
ur series compared with others.14,18-21 Nevertheless, to our
nowledge, this is the largest cohort of patients with
el22q11.2 identified as neonates requiring CCS and with
rospective follow-up data.
onclusions
eonates with chromosome 22q11.2 deletion who undergo
eonatal CCS have a significantly worse neurodevelopmen-
ABLE 3. Neurodevelopmental outcomes of 13 survivors ag
atched survivors (group 2)
ental delay (MDI  70)
sychomotor delay (PDI  70)
ental and/or psychomotor delay (MDI or PDI  70)
ehavioral indices, No. with nonoptimal scores (10th percentile
Orientation/engagement
Emotional regulation
Motor quality
Total score
evelopmental intervention
DI, Mental developmental index; PDI, psychomotor developmental index
ABLE 4. Pearson product moment correlations with P <
1 of mental and motor developmental levels and poten-
ially modifiable variables among 28 children ages 18 to 24
onths surviving after complex cardiac surgery at <6
eeks of age*
MDI PDI
r P value r P value
reoperative lowest PaO2 — — 0.411 .030
ays in hospital .348 .070 0.344 .082
ays ventilated — — 0.325 .092
el22q11.2 .548 .003 0.792 .000
DI, Mental developmental index; PDI, psychomotor developmental index.
There were 13 children with del22q11.2 and 15 comparison children.
78 The Journal of Thoracic and Cardiovascular Surgery ● Septeal outcome when evaluated at 18 to 24 months of age
ompared with a matched group without del22q11.2. This
dverse neurodevelopmental outcome is characterized by
ignificantly lower MDI and PDI scores and significantly
igher rates of motor and mental delay. This information
uggests that the adverse outcomes for those with
el22q11.2 are strongly associated with the chromosomal
bnormality and are associated to a lesser extent with the
eonatal cardiac surgery and associated events. This infor-
ation should allow more informed antenatal and postnatal
ounseling. Early targeted medical and rehabilitation inter-
ention through a dedicated multidisciplinary approach is
nstrumental for this fragile and at-risk patient population.
We thank the families of these children for their active partic-
pation in the developmental sites across Western Canada and their
ommitment to this project. We sincerely thank the research co-
rdinators who made this research possible: H. Christianson and
. Anseeuw-Deeks, Calgary, Alberta; V. Debooy, Winnipeg,
anitoba; T. Martindale, Saskatoon, Saskatchewan; and G. Alton
nd L. Sanders, Edmonton, Alberta.
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